Sunil Badve

Emory University

Full Professor(heuristic)

Breast Cancer Treatment Studies · Cancer Research

h-index84
i10-index259
Publications687
Citations42,676

Grants

15 total · 6 active

NIH #1R33CA309789-01

In Vitro Human INtraDuctal (HIND) Model of Early Stage Breast Cancer Progression Heterogeneity

Active
Amount
$396K
Period
2026-05-01 → 2029-04-30
PIs
3
Est. capacity / PI
~2 students

Awarded at GEORGIA INSTITUTE OF TECHNOLOGY

NIH #5R01CA281932-03

Early prediction of lethal phenotypes in triple negative breast cancer using multiscale, multi-modality platforms

Active
Amount
$618K
Period
2024-04-01 → 2029-03-31
PIs
2
Est. capacity / PI
~2 students

NIH #5R01CA281932-02

Early prediction of lethal phenotypes in triple negative breast cancer using multiscale, multi-modality platforms

Active
Amount
$605K
Period
2024-04-01 → 2029-03-31
PIs
2
Est. capacity / PI
~2 students

Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.

All Grants

15 total · 6 active

NIH #1R33CA309789-01

In Vitro Human INtraDuctal (HIND) Model of Early Stage Breast Cancer Progression Heterogeneity

Active
Amount
$396K
Period
2026-05-01 → 2029-04-30
PIs
3
Est. capacity / PI
~2 students

Awarded at GEORGIA INSTITUTE OF TECHNOLOGY

NIH #5R01CA281932-03

Early prediction of lethal phenotypes in triple negative breast cancer using multiscale, multi-modality platforms

Active
Amount
$618K
Period
2024-04-01 → 2029-03-31
PIs
2
Est. capacity / PI
~2 students

NIH #5R01CA281932-02

Early prediction of lethal phenotypes in triple negative breast cancer using multiscale, multi-modality platforms

Active
Amount
$605K
Period
2024-04-01 → 2029-03-31
PIs
2
Est. capacity / PI
~2 students

NIH #1R01CA281932-01A1

Early prediction of lethal phenotypes in triple negative breast cancer using multiscale, multi-modality platforms

Active
Amount
$615K
Period
2024-04-01 → 2029-03-31
PIs
2
Est. capacity / PI
~2 students

NIH #5R33CA297922-02

A Novel Multi-analyte Approach to Democratize Cancer Biobanking

Active
Amount
$446K
Period
2025-04-01 → 2028-03-31
PIs
3
Est. capacity / PI
~1 students

Awarded at GE MEDICAL SYSTEMS INFORMATION TECHNOLOGIES, INC

NIH #1R33CA297922-01

A Novel Multi-analyte Approach to Democratize Cancer Biobanking

Active
Amount
$440K
Period
2025-04-01 → 2028-03-31
PIs
3
Est. capacity / PI
~1 students

Awarded at GE MEDICAL SYSTEMS INFORMATION TECHNOLOGIES, INC

NIH #5R01CA194600-05

(PQC3) Ethnicity-determined immune response and DCIS outcome

Amount
$479K
Period
2015-08-04 → 2021-07-31
PIs
2
Est. capacity / PI
~0 students

Awarded at INDIANA UNIVERSITY INDIANAPOLIS

NIH #5R01CA194600-04

(PQC3) Ethnicity-determined immune response and DCIS outcome

Amount
$180K
Period
2015-08-04 → 2020-07-31
PIs
2
Est. capacity / PI
~0 students

Awarded at INDIANA UNIVERSITY INDIANAPOLIS

NIH #5R01CA194600-03

(PQC3) Ethnicity-determined immune response and DCIS outcome

Amount
$676K
Period
2015-08-04 → 2019-07-31
PIs
2
Est. capacity / PI
~0 students

Awarded at INDIANA UNIVERSITY INDIANAPOLIS

NIH #5R01CA194600-02

(PQC3) Ethnicity-determined immune response and DCIS outcome

Amount
$685K
Period
2015-08-04 → 2019-07-31
PIs
2
Est. capacity / PI
~0 students

Awarded at INDIANA UNIVERSITY INDIANAPOLIS

NIH #1R01CA194600-01

(PQC3) Ethnicity-determined immune response and DCIS outcome

Amount
$707K
Period
2015-08-04 → 2019-07-31
PIs
2
Est. capacity / PI
~0 students

Awarded at INDIANA UNIVERSITY INDIANAPOLIS

NIH #5R21CA195152-02

Computerized morphologic-molecular predictor of progression in DCIS

Amount
$202K
Period
2015-04-01 → 2018-03-31
PIs
2
Est. capacity / PI
~0 students

Awarded at CASE WESTERN RESERVE UNIVERSITY

NIH #1R21CA195152-01

Computerized morphologic-molecular predictor of progression in DCIS

Amount
$186K
Period
2015-04-01 → 2017-03-31
PIs
2
Est. capacity / PI
~0 students

Awarded at CASE WESTERN RESERVE UNIVERSITY

NIH #3R41CA174035-01S1

Evaluation of In Vitro Companion Diagnostic Monoclonal Antibodies for Use in a St

Amount
$150K
Period
2012-09-25 → 2014-03-31
PIs
2
Est. capacity / PI
~0 students

Awarded at INTICA BIOMEDICAL, INC.

NIH #1R41CA174035-01

Evaluation of In Vitro Companion Diagnostic Monoclonal Antibodies for Use in a St

Amount
$267K
Period
2012-09-25 → 2014-03-31
PIs
2
Est. capacity / PI
~0 students

Awarded at INTICA BIOMEDICAL, INC.

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 20 of 44
Open author page on OpenAlex →